Lu AE58054

· H. Lundbeck A/S

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Lu AE58054, covering 2012-01-06 to 2018-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease [Phase 3]

See pricing